Follow The Filings

BWA Borgwarner Inc.

Consumer Discretionary, filed as BORGWARNER INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Bought by 1 manager in 2026 Q2, sold by 2

  • 3 Owners
  • Max 0.0%
  • $18M
  • 1 new 2 reduce

In 2026 Q2 George Soros opened a position in Borgwarner, while John Rogers and Bill Nygren / Oakmark trimmed.

Who owns this now

Largest portfolio weights among holders, up to 0.0% (John Rogers, Ariel Investments). Not free-float ownership.

  1. John Rogers Reduce 0.04%
  2. Bill Nygren / Oakmark Reduce 0.02%
  3. George Soros New 0.02%

Who owns BWA

Sorted by value, long equity only, as of 2026 Q2.

History
Bill Nygren / Oakmark, Harris Associates L P 0.02% Reduce −12.8% 193,743 $13M History
John Rogers, Ariel Investments 0.04% Reduce −15.3% 55,049 $3.7M History
George Soros, Soros Fund Management 0.02% New 0.02% 19,400 $1.3M History

3 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by BWA's executives, directors and 10% owners in the last 12 months, from their Form 4s

All BWA insider trades
  • $501K bought by 1 insider
  • $17.6M sold by 11 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Michael S Hanley Director
    Sale
    $328K 5,000 shares at $65.51 13% of stake
    Traded Aug 28 Filed Sep 1
    ↗
  2. Tonit M Calaway EVP, CAO, Gen Counsel & Sec
    Sale
    $1.5M 22,000 shares at $66.26 23% of stake
    Traded Aug 24 Filed Aug 25
    ↗
  3. Rajesh Kalathur Director
    Buy
    $501K 7,407 shares at $67.59 New stake
    Traded Aug 19 Filed Aug 20
    ↗
  4. Amy B. Kulikowski VP & Chief Accounting Officer
    Sale
    $199K 2,900 shares at $68.60 23% of stake
    Traded Aug 18 Filed Aug 20
    ↗
  5. Stefan Demmerle Vice President
    Sale
    $70K 1,000 shares at $70.00 0.5% of stake
    Traded Aug 17 Filed Aug 18
    ↗
  6. Tonit M Calaway EVP, CAO, Gen Counsel & Sec
    Sale
    $3.1M 44,000 shares at $69.65 32% of stake
    Traded Aug 17 Filed Aug 18
    ↗
  7. Isabelle McKenzie Vice President
    Sale
    $317K 4,500 shares at $70.39 7.8% of stake
    Traded Aug 17 Filed Aug 18
    ↗
  8. Shaun McAlmont Director
    Sale
    $486K 7,000 shares at $69.36 28% of stake
    Traded Aug 17 Filed Aug 18
    ↗
  9. Sailaja Shankar Director
    Sale
    $365K 5,000 shares at $73.08 28% of stake
    Traded Jun 5 Filed Jun 8
    ↗
  10. Volker Weng Vice President
    Sale
    $362K 5,000 shares at $72.35 5.9% of stake
    Traded May 28 Filed May 29
    ↗
  11. Volker Weng Vice President
    Sale
    $339K 5,000 shares at $67.71 5.6% of stake
    Traded May 14 Filed May 15
    ↗
  12. Stefan Demmerle Vice President
    Sale
    $325K 5,000 shares at $65.00 2.4% of stake
    Traded May 13 Filed May 14
    ↗
  13. Joseph F. Fadool CEO
    Sale
    $2M 29,000 shares at $67.31 6.7% of stake
    Traded May 13 Filed May 14
    ↗
  14. Isabelle McKenzie Vice President
    Sale
    $222K 3,500 shares at $63.35 5.7% of stake
    Traded May 12 Filed May 13
    ↗
  15. Tania Wingfield EVP & CHRO
    Sale
    $316K 5,000 shares at $63.24 12% of stake
    Traded May 11 Filed May 12
    ↗

Also filed in the last 12 months, not counted as buying or selling: 45 stock grants and 21 share withholdings for taxes.

Congress

1 member of Congress traded BWA in the last three years: 1 buy and 1 sale.

All Congress trades
  1. Julie Johnson D-TX-32Joint Sell $1K–$15K Apr 1, 2025 filed May 14, 2025
  2. Julie Johnson D-TX-32Joint Buy $1K–$15K Feb 12, 2025 filed Mar 12, 2025

SEC filings

Recent issuer filings from EDGAR, 14 shown.

Filed Form Detail Links
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 7.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
8-K 5.02 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.02,5.07,7.01,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc

Source: SEC EDGAR submissions, updated 1 day ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $14.2B $14.09B $14.32B
Gross profit $2.57B $2.65B $2.67B
Gross margin * 18.1% 18.8% 18.7%
Net income $625M $338M $277M
Net margin * 4.4% 2.4% 1.9%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $6.22B $6.52B $6.8B
Total non-current assets * $8.24B $7.47B $6.97B
Total assets $14.45B $13.99B $13.77B
Total current liabilities $3.77B $3.65B $3.28B
Total non-current liabilities * $4.62B $4.64B $4.87B
Total equity $5.83B $5.53B $5.44B

Cash flow

Metric FY2023 FY2024 FY2025
Net change in cash $196M $560M $219M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.